AKRO(Delisted)
Akero Therapeutics·NASDAQ
--
--(--)
2.38 / 10
Underperform
Fundamentals underperform (score: 2.38). CFOA/GPOA offer minor support, but ROE, ROA, and GMAR weaknesses dominate. Mixed factor rankings highlight defensive positioning with limited growth potential.
Analysis Checks(5/10)
EV/EBIT
Value-16.97
Score1/3
Weight9.12%
1M Return8.08%
Value-16.97
Score1/3
Weight9.12%
1M Return8.08%
GPM
Value-0.18
Score2/3
Weight10.61%
1M Return9.53%
Value-0.18
Score2/3
Weight10.61%
1M Return9.53%
PB-ROE
Value2.72
Score0/3
Weight8.92%
1M Return8.41%
Value2.72
Score0/3
Weight8.92%
1M Return8.41%
ROE
Value-0.23
Score1/3
Weight11.07%
1M Return9.36%
Value-0.23
Score1/3
Weight11.07%
1M Return9.36%
GPOA
Value0.20
Score2/3
Weight9.66%
1M Return8.63%
Value0.20
Score2/3
Weight9.66%
1M Return8.63%
ROA
Value-0.22
Score3/3
Weight13.71%
1M Return11.33%
Value-0.22
Score3/3
Weight13.71%
1M Return11.33%
GMAR
Value-0.14
Score1/3
Weight10.32%
1M Return9.30%
Value-0.14
Score1/3
Weight10.32%
1M Return9.30%
Income tax / Total profit (%)
Value-5.90
Score0/3
Weight-0.96%
1M Return-1.17%
Value-5.90
Score0/3
Weight-0.96%
1M Return-1.17%
CFOA
Value-0.18
Score2/3
Weight12.43%
1M Return10.51%
Value-0.18
Score2/3
Weight12.43%
1M Return10.51%
Asset-MV
Value-0.45
Score2/3
Weight15.12%
1M Return12.49%
Value-0.45
Score2/3
Weight15.12%
1M Return12.49%
EV/EBIT
Value-16.97
Score1/3
Weight9.12%
1M Return8.08%
Value-16.97
Score1/3
Weight9.12%
1M Return8.08%
ROA
Value-0.22
Score3/3
Weight13.71%
1M Return11.33%
Value-0.22
Score3/3
Weight13.71%
1M Return11.33%
GPM
Value-0.18
Score2/3
Weight10.61%
1M Return9.53%
Value-0.18
Score2/3
Weight10.61%
1M Return9.53%
GMAR
Value-0.14
Score1/3
Weight10.32%
1M Return9.30%
Value-0.14
Score1/3
Weight10.32%
1M Return9.30%
PB-ROE
Value2.72
Score0/3
Weight8.92%
1M Return8.41%
Value2.72
Score0/3
Weight8.92%
1M Return8.41%
Income tax / Total profit (%)
Value-5.90
Score0/3
Weight-0.96%
1M Return-1.17%
Value-5.90
Score0/3
Weight-0.96%
1M Return-1.17%
ROE
Value-0.23
Score1/3
Weight11.07%
1M Return9.36%
Value-0.23
Score1/3
Weight11.07%
1M Return9.36%
CFOA
Value-0.18
Score2/3
Weight12.43%
1M Return10.51%
Value-0.18
Score2/3
Weight12.43%
1M Return10.51%
GPOA
Value0.20
Score2/3
Weight9.66%
1M Return8.63%
Value0.20
Score2/3
Weight9.66%
1M Return8.63%
Asset-MV
Value-0.45
Score2/3
Weight15.12%
1M Return12.49%
Value-0.45
Score2/3
Weight15.12%
1M Return12.49%
Is AKRO undervalued or overvalued?
- AKRO scores 2.38/10 on fundamentals and holds a Premium valuation at present. Backed by its -26.09% ROE, 0.00% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 0.79% earnings growth, these metrics solidify its Underperform investment rating.
